Lin et al.57 used autologous dendritic cells incubated with LMP2 peptides to vaccinate patients with nasopharyngeal carcinoma; after four injections CD8 T-cell responses to LMP2 were induced by the peptides, which correlated with tumor regression in two of nine patients. The gene discussed is PSMB9; the disease is nasopharyngeal carcinoma.